Senile vertigo
Conditions
Interventions
treatment group:Basic treatment + Betahistine Mesylate Tablets + flavoured Wumei decotion prescription
Control group:Basic treatment + Betahistine Mesylate Tablets
Sponsors
Eye Hospital China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
65 Years to 89 Years
Inclusion criteria
Inclusion criteria: (1) Elderly patients aged =65 years; (2) conforming to the diagnostic criteria of western medicine and traditional Chinese medicine and conforming to Jueyin syndrome based on syndrome differentiation of six meridians; (3) When the patient was still in the attack stage with vertigo/dizziness symptoms; (4) If the subjects voluntarily participated in the clinical trial and signed the informed consent form the procedure met the requirements of GCP.
Exclusion criteria
Exclusion criteria: (1) patients with disturbance of consciousness aphasia dementia and unable to cooperate with clinical investigation; (2) patients with severe mental illness; (3) patients with serious heart liver and kidney diseases who are difficult to complete oral TCM treatment; (4) patients allergic to prescription ingredients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dizziness Handicap Inventory; | — |
Secondary
| Measure | Time frame |
|---|---|
| VAS;TCM syndrome score; | — |
Countries
China
Contacts
Public ContactShu Xin
Eye Hospital China Academy of Chinese Medical Sciences
Outcome results
None listed